In animal models, including ApcMin mice and AOM-treated mice, deletion of COX-2 or treatment with selective COX-2 inhibitors reduced tumor numbers, size, and multiplicity [44, 46, 47]. The gene discussed is PTGS2; the disease is neoplasm.